Fig. 1From: TIPE2 acts as a biomarker for GIST risk category and suppresses the viability and invasiveness of GIST cellsThe expression of TIPE2 was gradually down-regulated in accordance with GIST risk categories. a–c Representative immunohistochemical staining showed high TIPE2 expression in very low risk GIST tissues. d–f Representative immunohistochemical staining showed moderate TIPE2 expression in low risk GIST tissues. g–i Representative immunohistochemical staining showed low TIPE2 expression in intermediate risk GIST tissues. j–l Representative immunohistochemical staining showed negative TIPE2 expression in high risk GIST tissuesBack to article page